Amerikanische Gesellschaft für Hirudotherapie

Efficacy and Safety of Hirudotherapy for Improving Sperm Quality Parameters in Male Infertility: A Randomized Controlled Trial

Randomized controlled trial published in Health science reports (2026)

Zuletzt aktualisiert: June 18, 2026Geprüft von: ASH Editorial Board
Research article — evidence reviewArticle reference
Klinische StudienGenomik & ProteomikSpeichel-PharmakologieSicherheit & InfektionskontrolleAbtahi-Forooshani M et al. · Health science reports, 2026

Abstract

BACKGROUND AND AIMS: Male infertility, often characterized by impaired sperm parameters, remains a significant clinical challenge. This study aimed to evaluate the efficacy and safety of hirudotherapy (medicinal leech therapy) in improving sperm quality parameters in men with idiopathic infertility. METHODS: In this randomized controlled trial, 50 male volunteers aged 20-50 years were randomly assigned to either an experimental group receiving weekly leech therapy for 3 months (n = 25) or a control group receiving no intervention (n = 25). Semen parameters were assessed at baseline and after the intervention period. Evaluations included semen analysis according to WHO guidelines, sperm DNA fragmentation by TUNEL assay, protamine deficiency by chromomycin A3 staining, and assessments of sperm viability and morphology using flow cytometry and Diff-Quik staining. Statistical analyses were performed using SPSS version 21.0, with significance set at p < 0.05. RESULTS: Compared to the control group, leech therapy significantly improved several sperm quality parameters. Sperm concentration increased from 57.7 ± 17.1 to 63.4 ± 13.1 million/mL (p = 0.006). Total sperm count, progressive motility, and normal morphology also improved significantly (p < 0.05). DNA fragmentation decreased significantly in the experimental group compared to controls (mean difference: -3.9%; p = 0.04). Protamine deficiency also showed a significant reduction (p = 0.02). No adverse effects related to the intervention were observed. CONCLUSION: This randomized controlled trial suggests that hirudotherapy may improve sperm quality parameters, including concentration, motility, morphology, and DNA integrity, in men with idiopathic infertility. These findings support further investigation of leech therapy as a complementary approach to male infertility management. Trial Registration: IRCT20230502058045N.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article

Zusammenfassung

Male infertility, often characterized by impaired sperm parameters, remains a significant clinical challenge. This study aimed to evaluate the efficacy and safety of hirudotherapy (medicinal leech therapy) in improving sperm quality parameters in men with idiopathic infertility.

Warum dies für die Hirudotherapie relevant ist

Provides randomized controlled trial evidence. Contributes clinical evidence for the therapeutic application of leech therapy.

Zitation

Efficacy and Safety of Hirudotherapy for Improving Sperm Quality Parameters in Male Infertility: A Randomized Controlled Trial.

Abtahi-Forooshani M et al. · Health science reports, 2026

Verwandter klinischer Kontext

Zur ASH-Bibliothek hinzugefügt: March 18, 2026 · Letzte Aktualisierung der Website: June 18, 2026

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.